AIM ImmunoTech Inc. (AIM) Form S-1 — Jun 18, 2026
AIM ImmunoTech Inc. filed an S-1 registration statement on June 18, 2026, to facilitate the resale of up to 13,077,089 shares of its common stock by selling stockholders. These shares, comprising 771,503 PIPE shares and shares underlying pre-funded warrants, Class J warrants, and placement agent warrants, were issued in connection with a registered direct offering and concurrent private placement that closed on June 10, 2026. The company will not receive any proceeds from the resale of these shares, although it could receive approximately $5.5 million if the warrants are exercised for cash.
Key figures
- Shares Offered
- 13077089
- Shares Outstanding
- 27724245
- Current share price
- 0.4
- Dilution percentage
- 47.17
- Potential gross proceeds from warrants
- 5500000
Price after filing
Close on the filing date to close N calendar days later (from $0.40). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.